Table 4.
Characteristic | OR (95%CI) | P Value | P for LRT |
---|---|---|---|
METS-IR | 0.015 | ||
METS-IR < 49.30 | 0.91 (0.27–3.08) | 0.789 | |
METS-IR ≥ 49.30 | 1.74 (1.18–2.91) | 0.012 | |
TG/HDL-C | 0.039 | ||
TG/HDL-C < 1.48 | 2.13 (1.24–3.02) | 0.014 | |
TG/HDL-C ≥ 1.48 | 1.04 (0.67–1.61) | 0.858 | |
TyG-BMI | 0.044 | ||
TyG-BMI < 221.53 | 1.18 (0.78–1.76) | 0.871 | |
TyG-BMI ≥ 221.53 | 1.68 (1.22–1.94) | 0.024 |
The segmented regression model was also adjusted for age, hypertension, diabetes, coronary artery disease, stroke, leukocyte, erythrocyte, platelet, uric acid, AST, albumin, total bilirubin, eGFR, and TASC II classification. P for LRT refers to the likelihood ratio test